CN1995339A - Penicillin acylation enzyme-fixing carrier preparation method and carrying method - Google Patents
Penicillin acylation enzyme-fixing carrier preparation method and carrying method Download PDFInfo
- Publication number
- CN1995339A CN1995339A CN 200610155523 CN200610155523A CN1995339A CN 1995339 A CN1995339 A CN 1995339A CN 200610155523 CN200610155523 CN 200610155523 CN 200610155523 A CN200610155523 A CN 200610155523A CN 1995339 A CN1995339 A CN 1995339A
- Authority
- CN
- China
- Prior art keywords
- chitosan
- preparation
- solution
- carrier
- porous resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title description 14
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 title description 5
- 229930182555 Penicillin Natural products 0.000 title 1
- 230000010933 acylation Effects 0.000 title 1
- 238000005917 acylation reaction Methods 0.000 title 1
- 229940049954 penicillin Drugs 0.000 title 1
- 229920005989 resin Polymers 0.000 claims abstract description 45
- 239000011347 resin Substances 0.000 claims abstract description 45
- 229920001661 Chitosan Polymers 0.000 claims abstract description 43
- 108010073038 Penicillin Amidase Proteins 0.000 claims abstract description 26
- 108090000790 Enzymes Proteins 0.000 claims abstract description 23
- 102000004190 Enzymes Human genes 0.000 claims abstract description 23
- 125000000524 functional group Chemical group 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 11
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000006011 modification reaction Methods 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 238000012216 screening Methods 0.000 claims abstract description 4
- 230000003213 activating effect Effects 0.000 claims abstract description 3
- 238000000227 grinding Methods 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 230000004913 activation Effects 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N alpha-ketodiacetal Natural products O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 8
- 125000003277 amino group Chemical group 0.000 claims description 8
- 230000004048 modification Effects 0.000 claims description 8
- 238000012986 modification Methods 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 6
- 229920002307 Dextran Polymers 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- -1 polypropylene Polymers 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 5
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 4
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 230000001588 bifunctional effect Effects 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 229940015043 glyoxal Drugs 0.000 claims description 4
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims description 4
- 239000004584 polyacrylic acid Substances 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea group Chemical group NC(=S)N UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- FPOSCXQHGOVVPD-UHFFFAOYSA-N chloromethyl(trimethoxy)silane Chemical compound CO[Si](CCl)(OC)OC FPOSCXQHGOVVPD-UHFFFAOYSA-N 0.000 claims description 3
- 235000019830 sodium polyphosphate Nutrition 0.000 claims description 3
- ONRREFWJTRBDRA-UHFFFAOYSA-N 2-chloroethanamine;hydron;chloride Chemical compound [Cl-].[NH3+]CCCl ONRREFWJTRBDRA-UHFFFAOYSA-N 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 230000006196 deacetylation Effects 0.000 claims description 2
- 238000003381 deacetylation reaction Methods 0.000 claims description 2
- 125000003700 epoxy group Chemical group 0.000 claims description 2
- 238000010907 mechanical stirring Methods 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920000768 polyamine Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- 229960003511 macrogol Drugs 0.000 claims 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229920000915 polyvinyl chloride Polymers 0.000 claims 1
- 239000004800 polyvinyl chloride Substances 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- NBXZNTLFQLUFES-UHFFFAOYSA-N triethoxy(propyl)silane Chemical compound CCC[Si](OCC)(OCC)OCC NBXZNTLFQLUFES-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 239000003782 beta lactam antibiotic agent Substances 0.000 abstract description 7
- 239000002132 β-lactam antibiotic Substances 0.000 abstract description 7
- 229940124586 β-lactam antibiotics Drugs 0.000 abstract description 7
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 229920000307 polymer substrate Polymers 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 125000004185 ester group Chemical group 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 229910010272 inorganic material Inorganic materials 0.000 description 3
- 239000011147 inorganic material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 229920002538 Polyethylene Glycol 20000 Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- CSGFFYNMTALICU-ZWNOBZJWSA-N adipyl-7-aminodesacetoxycephalosporanic acid Natural products CC1=C(N2[C@H](SC1)[C@H](NC(=O)CCCCC(O)=O)C2=O)C(O)=O CSGFFYNMTALICU-ZWNOBZJWSA-N 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- AXOFFTWUWPCDGJ-UHFFFAOYSA-N 2,2-dichloroethanamine;hydrochloride Chemical compound Cl.NCC(Cl)Cl AXOFFTWUWPCDGJ-UHFFFAOYSA-N 0.000 description 1
- VKPPFDPXZWFDFA-UHFFFAOYSA-N 2-chloroethanamine Chemical compound NCCCl VKPPFDPXZWFDFA-UHFFFAOYSA-N 0.000 description 1
- ULGJWNIHLSLQPZ-UHFFFAOYSA-N 7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-n-[2-(1h-indol-3-yl)ethyl]heptanamide Chemical compound C1CCCC2=NC3=CC(Cl)=CC(Cl)=C3C(NCCCCCCC(=O)NCCC=3C4=CC=CC=C4NC=3)=C21 ULGJWNIHLSLQPZ-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010075344 Tryptophan synthase Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 108010003977 aminoacylase I Proteins 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960004841 cefadroxil Drugs 0.000 description 1
- NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006009 resin backbone Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
本发明公开了一种固定化青霉素酰化酶的制备方法,其特征在于:包括如下步骤:(1)将带有侧链官能团的多孔树脂进行研磨,筛选,干燥,活化后与壳聚糖溶液混合,烘干,得到固体;(2)将步骤(1)得到的固体加入极性亲水性溶剂中,加入助剂进行修饰反应后抽滤,洗涤,烘干得到多孔树脂载体;(3)将青霉素酰化酶负载于多孔树脂载体上;得到的固定化青霉素酰化酶。发明通过壳聚糖的生物相容性作用提高了酶的活性并维持较高稳定性,而且高分子聚合物基材具有良好的机械性能,使得本发明的固定化青霉素酰化酶更好的满足β-内酰胺抗生素工业化生产条件的要求。The invention discloses a preparation method of immobilized penicillin acylase, which is characterized in that it comprises the following steps: (1) grinding a porous resin with side chain functional groups, screening, drying, activating and mixing with chitosan solution mixing and drying to obtain a solid; (2) adding the solid obtained in step (1) into a polar hydrophilic solvent, adding an auxiliary agent for modification reaction, suction filtering, washing, and drying to obtain a porous resin carrier; (3) The penicillin acylase is loaded on a porous resin carrier; the immobilized penicillin acylase is obtained. The invention improves the activity of the enzyme and maintains high stability through the biocompatibility of chitosan, and the high molecular polymer substrate has good mechanical properties, which makes the immobilized penicillin acylase of the present invention better meet Requirements for industrial production conditions of β-lactam antibiotics.
Description
技术领域technical field
本发明涉及一种用于固定青霉素酰化酶的载体的制备和负载方法,主要应用于β-内酰胺类抗生素及其母核的工业制备和合成过程。The invention relates to a preparation and loading method of a carrier for immobilizing penicillin acylase, which is mainly used in the industrial preparation and synthesis process of β-lactam antibiotics and their mother nuclei.
背景技术Background technique
二十世纪60年代早期β-内酰胺抗生素半合成工业渐渐兴起,这使得β-内酰胺的母核6-氨基青霉素烷酸(6-APA)成为重要的药物合成中间体。因此,人们首先开始通过青霉素酰化酶(PGA)裂解青霉素G来合成6-APA。随后,由于PGA独特的选择性,人们又研究利用PGA的选择催化作用,以6-APA或7-氨基去乙酸基头孢烷酸(7-ADCA)为β-内酰胺的母核,再加上适当的侧链来半合成β-内酰胺抗生素。In the early 1960s, the semi-synthetic industry of β-lactam antibiotics gradually emerged, which made 6-aminopenicillin alkanoic acid (6-APA), the mother nucleus of β-lactam, an important drug synthesis intermediate. Therefore, people first started to synthesize 6-APA by cleaving penicillin G by penicillin acylase (PGA). Subsequently, due to the unique selectivity of PGA, people studied the selective catalysis of PGA, using 6-APA or 7-amino deacetoxycephalosporanic acid (7-ADCA) as the mother nucleus of β-lactam, plus Appropriate side chains for the semisynthesis of β-lactam antibiotics.
四十余年来,经过不断的筛选和基因重组的PGA变得越来越稳定,酶的生产能力也不断的得到提高,再加上有效的固定化方法使得酶的回收变成可能,该方法的成本也被大大的降低。For more than 40 years, PGA has become more and more stable through continuous screening and genetic recombination, and the production capacity of enzymes has also been continuously improved. Coupled with effective immobilization methods, the recovery of enzymes has become possible. This method The cost is also greatly reduced.
现在,通过酶的这一催化作用,全世界一年可以生产20000吨的6-APA,而相应的β-内酰胺类抗生素,如头孢氨苄,阿莫西林和头孢羟氨苄等,也已经逐渐实现了工业化的酶促合成。Now, through the catalysis of enzymes, the world can produce 20,000 tons of 6-APA a year, and the corresponding β-lactam antibiotics, such as cephalexin, amoxicillin and cefadroxil, have also been gradually realized. industrial enzymatic synthesis.
但值得注意的是,有效的PGA固定化方法是酶促裂解青霉素G和β-内酰胺抗生素半合成的关键。所以现在对于这一领域的研究也相当重视。However, it is worth noting that an efficient PGA immobilization method is the key to enzymatic cleavage of penicillin G and β-lactam antibiotic semisynthesis. So much attention is paid to research in this field.
许多材料都被研究和开发用来进行青霉素酰化酶的固定化,总体说来这些材料可以分为三大类:Many materials have been researched and developed for the immobilization of penicillin acylase, in general these materials can be divided into three categories:
一、高分子聚合物:主要是一些聚丙烯酸及其衍生化的多孔性树脂材料,有代表性的如Eupergit C和Amberlite系列树脂。1. High molecular polymer: mainly some polyacrylic acid and its derivatized porous resin materials, such as Eupergit C and Amberlite series resins.
二、生物相容性材料:这一类主要是一些天然或具有一定生物相容性的材料,例如壳聚糖,葡聚糖,海藻酸钠,明胶等等。2. Biocompatible materials: This category is mainly some natural or biocompatible materials, such as chitosan, dextran, sodium alginate, gelatin and so on.
三、无机材料:这主要是一些具有多孔性的无机材料,例如分子筛,硅藻土或硅胶等等。但是这一类材料通常会通过一些化学方法进行改性。3. Inorganic materials: These are mainly porous inorganic materials, such as molecular sieves, diatomaceous earth or silica gel, etc. But this type of material is usually modified by some chemical methods.
这三种材料已广泛用于酶固定化之中,不仅仅是青霉素酰化酶的固定,但是这三种材料各有利弊。通常说来,无机材料载体具有较好的机械性能和较高的比表面积,而高分子聚合物则有较高的固定化效率和较好的回收率及选择性。而生物材料则由于它们较好的生物相容性,会给固定化的酶提供一些帮助,如提高它们的化学稳定性,减小固定化过程中酶的失活,但是往往这一类载体的机械性能不是很理想,对于工业上苛刻的反应条件也不能很好的适应。These three materials have been widely used in the immobilization of enzymes, not only the immobilization of penicillin acylase, but each of the three materials has advantages and disadvantages. Generally speaking, inorganic material carriers have better mechanical properties and higher specific surface area, while polymers have higher immobilization efficiency and better recovery and selectivity. Biomaterials, due to their better biocompatibility, will provide some help to immobilized enzymes, such as improving their chemical stability and reducing the inactivation of enzymes during immobilization, but often this type of carrier The mechanical properties are not very ideal, and it cannot be well adapted to the harsh reaction conditions in industry.
发明内容Contents of the invention
本发明提供了一种用于固定青霉素酰化酶的载体的制备和负载方法,以具有一定活性官能团的高分子聚合物为基材,再通过壳聚糖和一些助剂的吸附修饰作用,对载体内部孔道表面进行修饰,使得高分子聚合物载体内部孔道表面更适于酶的吸附和固定,以获得更高的稳定性和活性。The invention provides a method for preparing and loading a carrier for immobilizing penicillin acylase, using a high molecular polymer with a certain active functional group as the base material, and then through the adsorption and modification of chitosan and some auxiliary agents, the The surface of the internal pores of the carrier is modified to make the surface of the internal pores of the polymer carrier more suitable for the adsorption and immobilization of enzymes to obtain higher stability and activity.
这种用于固定青霉素酰化酶的载体的制备方法包括如下步骤:The preparation method of this carrier for immobilizing penicillin acylase comprises the steps:
(1)将带有侧链官能团的多孔树脂进行研磨,筛选,干燥,活化后与壳聚糖溶液混合,烘干得到固体;(1) Grinding the porous resin with side chain functional groups, screening, drying, mixing with chitosan solution after activation, and drying to obtain solid;
(2)将步骤(1)得到的固体加入极性亲水性溶剂中,在机械搅拌转速100~800r/min,时间10~100分钟后,调节pH值为7~11,加入助剂进行修饰反应,修饰反应2~10小时后抽滤,洗涤,烘干。(2) Add the solid obtained in step (1) into a polar hydrophilic solvent, adjust the pH value to 7-11 after the mechanical stirring speed is 100-800r/min for 10-100 minutes, and add additives for modification After reaction and modification reaction for 2-10 hours, filter with suction, wash and dry.
所述的多孔树脂为颗粒状的固体多孔树脂,粒径为0.05~2.0mm,孔径为2~100nm。The porous resin is a granular solid porous resin with a particle diameter of 0.05-2.0 mm and a pore diameter of 2-100 nm.
所述的多孔树脂分子骨架为聚丙烯、聚苯乙烯、聚丙烯酸、聚乙烯、聚丙烯酸酯、聚氨酯等,多孔树脂带有的侧链官能团为羟基、氨基、羧基、磺酸基、硫脲基、膦酸基或环氧基中的一种或多种。The molecular skeleton of the porous resin is polypropylene, polystyrene, polyacrylic acid, polyethylene, polyacrylate, polyurethane, etc., and the side chain functional groups of the porous resin are hydroxyl, amino, carboxyl, sulfonic acid, and thiourea groups. , one or more of phosphonic acid groups or epoxy groups.
所述的壳聚糖溶液是将壳聚糖溶于乙酸或盐酸溶液中,壳聚糖的质量百分比浓度为0.5%~10.0%,所述的壳聚糖为生物级或工业级壳聚糖,去乙酰度为60%~95%,分子量为10000~500000。所述的壳聚糖与树脂的质量比在1∶1~1∶50之间。Described chitosan solution is that chitosan is dissolved in acetic acid or hydrochloric acid solution, and the mass percent concentration of chitosan is 0.5%~10.0%, and described chitosan is biological grade or industrial grade chitosan, The degree of deacetylation is 60% to 95%, and the molecular weight is 10,000 to 500,000. The mass ratio of the chitosan to the resin is between 1:1 and 1:50.
所述的壳聚糖溶液中可添加有质量百分比浓度为1.0%~10%亲水性的物质,所述的亲水性的物质为聚乙二醇(PEG)2000、聚乙二醇(PEG)5000、聚乙二醇(PEG)20000、葡聚糖、葡聚醛或聚胺类。The chitosan solution can be added with a mass percent concentration of 1.0% to 10% hydrophilic substance, and the hydrophilic substance is polyethylene glycol (PEG) 2000, polyethylene glycol (PEG ) 5000, polyethylene glycol (PEG) 20000, dextran, dextran or polyamines.
步骤(2)中所述的极性亲水性溶剂为水、二甲基亚砜(DMSO)、二甲基甲酰胺(DMF)、丙酮、甲醇、乙醇中的一种或几种。The polar hydrophilic solvent described in step (2) is one or more of water, dimethylsulfoxide (DMSO), dimethylformamide (DMF), acetone, methanol, and ethanol.
步骤(2)中所述的助剂为甲醛、乙醛、戊二醛、环氧氯丙烷、三甲氧基氯甲基硅烷、氨丙基三乙氧基硅烷或2-氯乙胺/盐酸盐中的一种或几种,助剂添加量为修饰反应体系重量的1.0%~10%。The auxiliary agent described in the step (2) is formaldehyde, acetaldehyde, glutaraldehyde, epichlorohydrin, trimethoxychloromethylsilane, aminopropyltriethoxysilane or 2-chloroethylamine/hydrochloric acid One or several kinds of salts, the additive amount is 1.0%-10% of the weight of the modification reaction system.
按本发明所述的制备方法制备的载体负载青霉素酰化酶的方法,包括如下步骤:The method for the carrier-loaded penicillin acylase prepared by the preparation method of the present invention comprises the following steps:
(a)将所述的载体用无机助剂活化,所述的无机助剂为氨水、碳酸氢钠、碳酸钠或多聚磷酸钠的水溶液,浓度为0.1~4.0mol/L,活化温度20~70℃,活化时间6~20小时;(a) Activating the carrier with an inorganic auxiliary agent, the inorganic auxiliary agent is an aqueous solution of ammonia water, sodium bicarbonate, sodium carbonate or sodium polyphosphate, the concentration is 0.1-4.0mol/L, and the activation temperature is 20-20 70°C, activation time 6-20 hours;
(b)将无机助剂活化后的载体用双官能团试剂进行活化,所述的双官能团试剂为甲醛、乙二醛或戊二醛的水溶液,质量百分比浓度为0.5%~5.0%,活化温度20~70℃,活化时间1~8小时;(b) Activate the carrier activated by the inorganic auxiliary agent with a bifunctional reagent, the bifunctional reagent is an aqueous solution of formaldehyde, glyoxal or glutaraldehyde, the mass percent concentration is 0.5% to 5.0%, and the activation temperature is 20 ~70℃, activation time 1~8 hours;
(c)活化后的载体在温度20~70℃陈化12~48小时,与浓度为50~2000U/ml青霉素酰化酶的游离酶溶液混合,5~40℃反应12~60小时,在体系中加入硼氢化钠,每毫升游离酶溶液的硼氢化钠用量为0.05~10mg,反应15~200min,抽滤,洗涤,室温真空干燥可得细颗粒状或粉末状的青霉素酰化酶固定化产物。(c) The activated carrier is aged at a temperature of 20-70° C. for 12-48 hours, mixed with a free enzyme solution of penicillin acylase at a concentration of 50-2000 U/ml, and reacted at 5-40° C. for 12-60 hours. Add sodium borohydride to the solution, the amount of sodium borohydride per milliliter of free enzyme solution is 0.05-10 mg, react for 15-200 minutes, filter with suction, wash, and dry in vacuum at room temperature to obtain fine-grained or powdered penicillin acylase immobilized product .
所述的载体负载青霉素酰化酶的方法同样适用于其他一些种类酶的负载,只要将步骤(c)中的游离青霉素酰化酶的溶液换成其他一些游离酶的溶液即可,如水解酶,氧化还原酶,合成酶等等。优选氨基酰化酶,猪胰脂肪酶,色氨酸合成酶,脲酶。The method of the carrier-loaded penicillin acylase is also applicable to the loading of some other types of enzymes, as long as the solution of the free penicillin acylase in step (c) is replaced with a solution of some other free enzymes, such as hydrolase , oxidoreductases, synthetases, etc. Preferred are aminoacylase, porcine pancreatic lipase, tryptophan synthase, urease.
所述的负载青霉素酰化酶的方法的步骤(c)中,可以根据需要确定载体、游离酶溶液用量的关系,一般每克载体使用游离酶溶液2~20毫升。In the step (c) of the method for loading penicillin acylase, the relationship between the amount of the carrier and the free enzyme solution can be determined as required, and generally 2-20 ml of the free enzyme solution is used per gram of the carrier.
制备本发明载体首先要选用一种具有大孔颗粒状树脂作为基材,例如,美国罗门哈斯公司的Amberlite IRC76C,Amberlite 1000Na;国内离子交换树脂通用型号的D101,D201,D316等常见树脂。这种大孔树脂通常含有一定的官能团,如羟基,氨基,羧基,磺酸基,硫脲基,膦酸基,环氧基,以及它们的衍生化基团等。壳聚糖首先通过多孔的吸附作用吸附进树脂的孔道内,再通过不同助剂的作用将其牢靠的与树脂连接在一起。To prepare the carrier of the present invention, a granular resin with macropores should be selected as the base material, for example, Amberlite IRC76C and Amberlite 1000Na from Rohm and Haas Company of the United States; common resins such as D101, D201, and D316, which are common types of ion exchange resins in China. This macroporous resin usually contains certain functional groups, such as hydroxyl, amino, carboxyl, sulfonic acid, thiourea, phosphonic acid, epoxy, and their derivatized groups. Chitosan is firstly adsorbed into the pores of the resin through porous adsorption, and then firmly connected with the resin through the action of different additives.
以三个例子说明:To illustrate with three examples:
一个是以羟基为官能团的树脂与壳聚糖共价结合的原理,由于树脂上具有很多的羟基,因此可以通过这些羟基,利用三甲氧基(或三乙氧基)氯烷基硅烷与壳聚糖的氨基发生作用,从而达到一个修饰化的目的,将壳聚糖固定并修饰在树脂上。One is the principle of covalent bonding of resins with hydroxyl groups as functional groups and chitosan. Since there are many hydroxyl groups on the resin, it is possible to use trimethoxy (or triethoxy) chloroalkylsilane and chitosan through these hydroxyl groups. The amino group of the sugar acts to achieve a modification purpose, and the chitosan is fixed and modified on the resin.
一个是以氨基为官能团的树脂与壳聚糖共价结合的原理,由于树脂上具有很多的氨基,因此可以通过这些氨基,利用环氧氯丙烷的交联作用,与壳聚糖的氨基发生反应,从而达到一个修饰化的目的,将壳聚糖固定并修饰在树脂上。One is the principle of covalent bonding between resins with amino groups as functional groups and chitosan. Since there are many amino groups on the resin, these amino groups can be used to react with the amino groups of chitosan through the crosslinking effect of epichlorohydrin. , so as to achieve a modified purpose, chitosan is fixed and modified on the resin.
一个是以酯基为官能团的树脂与壳聚糖共价结合的原理,由于树脂上具有很多的酯基,因此可以通过这些酯基,再添加入二氯乙胺(盐酸盐),与壳聚糖的酯基发生反应,从而达到一个修饰化的目的,将壳聚糖固定并修饰在树脂上。One is the principle of covalent bonding of resin with ester group as functional group and chitosan. Since there are many ester groups on the resin, dichloroethylamine (hydrochloride) can be added through these ester groups to interact with the shell. The ester group of the polycan reacts to achieve the purpose of modification, and the chitosan is fixed and modified on the resin.
这样,壳聚糖修饰的多孔树脂载体就可以通过这些不同的方法得以制备,然后采用常见的共价固定法,利用壳聚糖的氨基和双官能团试剂的活化作用对酶进行共价固定。In this way, chitosan-modified porous resin supports can be prepared by these different methods, and then the common covalent immobilization method is used to covalently immobilize the enzyme by utilizing the amino group of chitosan and the activation of bifunctional reagents.
在这一载体中,不仅仅需要利用到壳聚糖较高的氨基密度,给共价交联提供基础和保障,还需要利用壳聚糖糖环上丰富的羟基,只有这些羟基才能给固定上的酶提供一个优良的亲水性微环境,这样才能保持酶具有较高的水活度,使酶失活率大大降低,保持一个较高的活力稳定性。所以,这也是采用壳聚糖作为树脂载体修饰剂的一个重要目的之一。In this carrier, it is not only necessary to utilize the high amino group density of chitosan to provide the basis and guarantee for covalent crosslinking, but also to utilize the abundant hydroxyl groups on the sugar ring of chitosan, only these hydroxyl groups can be used for immobilization. The enzyme provides an excellent hydrophilic microenvironment, so that the enzyme can maintain a high water activity, greatly reduce the enzyme inactivation rate, and maintain a high activity stability. Therefore, this is also one of the important purposes of using chitosan as a resin carrier modifier.
综上看来,第一,多孔大孔型树脂为壳聚糖的吸附和酶的吸附提供了基础;第二,壳聚糖稳定的共价修饰于树脂表面提高了整个载体的稳定性;第三,壳聚糖丰富的羟基为酶提供了一个非常优良的微环境;第四,可变的树脂骨架和官能团以及不同的共价修饰过程使得固定化载体具有多样性以适应不同酶和使用环境的需求。In summary, first, the porous macroporous resin provides the basis for the adsorption of chitosan and enzyme; second, the stable covalent modification of chitosan on the surface of the resin improves the stability of the entire carrier; Third, the rich hydroxyl groups of chitosan provide a very good microenvironment for enzymes; fourth, the variable resin backbone and functional groups and different covalent modification processes make the immobilized carrier diverse to adapt to different enzymes and use environments demand.
这样,既通过壳聚糖的生物相容性作用保留了酶自身较高的稳定性和活性,又因为有高分子聚合物作为基材而具有良好的机械性能和化学稳定性,使得整个固定化产物能较好的适应β-内酰胺抗生素工业化生产中恶劣的条件。In this way, the high stability and activity of the enzyme itself is retained through the biocompatibility of chitosan, and because of the high molecular polymer as the substrate, it has good mechanical properties and chemical stability, making the whole immobilized The product can better adapt to harsh conditions in the industrial production of β-lactam antibiotics.
附图说明Description of drawings
图1为树脂未修饰前的剖面SEM图Figure 1 is the cross-sectional SEM image of the resin before modification
图2为壳聚糖修饰树脂后的剖面SEM图Figure 2 is the cross-sectional SEM image of chitosan modified resin
具体实施方式Detailed ways
实施例1Example 1
取5.0g聚甲基丙烯酸甲酯球状多孔树脂研磨并过筛得粒径为0.5mm的树脂颗粒。将1.0g壳聚糖溶于50ml的2%乙酸溶液中,再加入0.5gPEG20000,配成透明澄清溶液。将树脂与壳聚糖溶液混合均匀,40℃烘干。将混合固体转入圆底烧瓶中,加入50ml水,机械搅拌200r/min,30分钟后,用NaOH水溶液调节pH值为10,加入0.5g 2-氯乙胺盐酸盐,控制温度40℃,反应5小时后,抽滤,洗涤,40℃烘干。5.0 g of polymethyl methacrylate spherical porous resin was ground and sieved to obtain resin particles with a particle size of 0.5 mm. Dissolve 1.0 g of chitosan in 50 ml of 2% acetic acid solution, and then add 0.5 g of PEG20000 to form a transparent and clear solution. Mix the resin and chitosan solution evenly, and dry at 40°C. Transfer the mixed solids into a round-bottomed flask, add 50ml of water, and stir mechanically at 200r/min. After 30 minutes, adjust the pH value to 10 with NaOH aqueous solution, add 0.5g of 2-chloroethylamine hydrochloride, and control the temperature at 40°C. After reacting for 5 hours, filter with suction, wash, and dry at 40°C.
取1.0g制备好的载体于锥形瓶中,加入1mol/L的碳酸氢钠溶液,温度50℃,反应12小时,分离,再加入10ml 2.0%的乙二醛溶液,摇床振荡,200r/min,温度控制为40℃。6小时后取出,30℃陈化24小时,加入游离的青霉素酰化酶溶液400U/ml共5ml,10℃反应24小时,再在体系中加入NaBH4 15mg,处理30min后,抽滤,洗涤,室温真空干燥。分离可得固定化青霉素酰化酶产品,活力约为600~800U/g。Take 1.0 g of the prepared carrier in a Erlenmeyer flask, add 1 mol/L sodium bicarbonate solution, react at 50°C for 12 hours, separate, then add 10 ml of 2.0% glyoxal solution, shake on a shaking table, 200r/ min, the temperature is controlled at 40°C. Take it out after 6 hours, age at 30°C for 24 hours, add 400U/ml of free penicillin acylase solution, 5ml in total, react at 10°C for 24 hours, then add 15mg of NaBH 4 to the system, treat for 30min, suction filter, wash, Dry under vacuum at room temperature. The product of immobilized penicillin acylase can be obtained by separation, the activity is about 600-800U/g.
实施例2Example 2
取20.0g聚对苯乙烯烷羟基球状多孔树脂研磨并过筛得粒径为0.5mm的树脂颗粒。将1.0g壳聚糖溶于50ml的1%盐酸溶液中,再加入0.5gPEG2000,配成透明澄清溶液。将树脂与壳聚糖溶液混合,40℃烘干。将混合固体转入圆底烧瓶中,加入50ml DMSO,30分钟后,机械搅拌500r/min,用NaOH水溶液调节pH值为9,加入5ml的三甲氧基氯甲基硅烷,控制温度60℃,反应4小时后,抽滤,洗涤,40℃烘干。20.0 g of poly(p-styrene alkylhydroxyl) spherical porous resin was ground and sieved to obtain resin particles with a particle size of 0.5 mm. Dissolve 1.0 g of chitosan in 50 ml of 1% hydrochloric acid solution, and then add 0.5 g of PEG2000 to form a transparent and clear solution. Mix the resin with the chitosan solution and dry at 40°C. Transfer the mixed solid into a round bottom flask, add 50ml DMSO, after 30 minutes, mechanically stir at 500r/min, adjust the pH value to 9 with NaOH aqueous solution, add 5ml of trimethoxychloromethylsilane, control the temperature at 60°C, and react After 4 hours, filter with suction, wash, and dry at 40°C.
取1.0g制备好的载体于锥形瓶中,加入1mol/L的氨水,温度60℃,反应15小时,分离,再加入10ml 2.0%的戊二醛溶液,摇床振荡,200r/min,温度控制为40℃。4小时后取出,30℃陈化36小时,加入游离的青霉素酰化酶溶液600U/ml共5ml,20℃反应36小时,再在体系中加入NaBH410mg,处理60min后,抽滤,洗涤,室温真空干燥。分离可得固定化青霉素酰化酶产品,活力约为500~700U/g。Take 1.0 g of the prepared carrier in an Erlenmeyer flask, add 1 mol/L ammonia water, react at 60°C for 15 hours, separate, then add 10 ml of 2.0% glutaraldehyde solution, vibrate on a shaker, 200r/min, temperature Controlled at 40°C. Take it out after 4 hours, age at 30°C for 36 hours, add 600U/ml of free penicillin acylase solution, 5ml in total, react at 20°C for 36 hours, then add NaBH 4 10mg to the system, treat for 60min, suction filter, wash, Dry under vacuum at room temperature. The product of immobilized penicillin acylase can be obtained by separation, the activity is about 500-700U/g.
实施例3Example 3
取10.0g聚丙烯酸叔氨基多孔树脂研磨并过筛得粒径为0.5mm的树脂颗粒。将1.0壳聚糖溶于50ml的1%盐酸溶液中,再加入0.5g葡萄糖,配成透明澄清溶液。将树脂与壳聚糖溶液混合均匀,40℃烘干。将混合固体转入圆底烧瓶中,加入25ml DMF和25ml乙醇,30分钟后,机械搅拌500r/min,用NaOH水溶液调节pH值为11,加入5ml的环氧氯丙烷,控制温度90℃,反应8小时后,抽滤,洗涤,50℃烘干。10.0 g of polyacrylic acid tertiary amino porous resin was ground and sieved to obtain resin particles with a particle size of 0.5 mm. Dissolve 1.0 g of chitosan in 50 ml of 1% hydrochloric acid solution, then add 0.5 g of glucose to form a transparent and clear solution. Mix the resin and chitosan solution evenly, and dry at 40°C. Transfer the mixed solid into a round bottom flask, add 25ml DMF and 25ml ethanol, after 30 minutes, mechanically stir at 500r/min, adjust the pH value to 11 with NaOH aqueous solution, add 5ml of epichlorohydrin, control the temperature at 90°C, and react After 8 hours, filter with suction, wash, and dry at 50°C.
取1.0g制备好的载体于锥形瓶中,加入1mol/L的多聚磷酸钠溶液,温度30℃,反应12小时,分离,再加入10ml 2.0%的乙二醛溶液,摇床振荡,200r/min,温度控制为40℃。6小时后取出,30℃陈化48小时,加入游离的青霉素酰化酶溶液加入游离的青霉素酰化酶溶液800U/ml共5ml,30℃反应50小时,再在体系中加入NaBH4 20mg,处理150min后,抽滤,洗涤,室温真空干燥,可得固定化青霉素酰化酶产品,活力约为700~900U/g。Take 1.0g of the prepared carrier in a Erlenmeyer flask, add 1mol/L sodium polyphosphate solution, react at 30°C for 12 hours, separate, then add 10ml of 2.0% glyoxal solution, oscillate on a shaking table, 200r /min, the temperature is controlled at 40°C. Take it out after 6 hours, age at 30°C for 48 hours, add free penicillin acylase solution, add free penicillin acylase solution 800U/ml, a total of 5ml, react at 30°C for 50 hours, then add NaBH 4 20mg to the system to treat After 150 minutes, filter with suction, wash, and vacuum-dry at room temperature to obtain an immobilized penicillin acylase product with an activity of about 700-900 U/g.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101555239A CN100455664C (en) | 2006-12-28 | 2006-12-28 | Preparation and loading method of a carrier for immobilizing penicillin acylase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101555239A CN100455664C (en) | 2006-12-28 | 2006-12-28 | Preparation and loading method of a carrier for immobilizing penicillin acylase |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1995339A true CN1995339A (en) | 2007-07-11 |
CN100455664C CN100455664C (en) | 2009-01-28 |
Family
ID=38250542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101555239A Expired - Fee Related CN100455664C (en) | 2006-12-28 | 2006-12-28 | Preparation and loading method of a carrier for immobilizing penicillin acylase |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100455664C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104140961A (en) * | 2014-07-04 | 2014-11-12 | 浙江大学 | Immobilized lipase having Sn-1,3 specificity as well as preparation method and application of immobilized lipase |
CN109207466A (en) * | 2018-11-08 | 2019-01-15 | 山东鲁抗医药股份有限公司 | A kind of process for fixation and immobilised enzymes of PA ase |
CN110760496A (en) * | 2019-05-07 | 2020-02-07 | 宁波大学 | A kind of co-crosslinking immobilization method of penicillin G acylase |
WO2021249433A1 (en) * | 2020-06-10 | 2021-12-16 | 华南理工大学 | Carrier for immobilizing protein and preparation method therefor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2798932B2 (en) * | 1988-06-15 | 1998-09-17 | 株式会社東芝 | Drive device for charge-coupled device |
CN1164745C (en) * | 2001-05-15 | 2004-09-01 | 厦门大学 | Penicillin acylase and immobilization method of cells containing penicillin acylase |
CN1253566C (en) * | 2002-09-06 | 2006-04-26 | 华东理工大学 | Immobilized penicillin amidase carrier and its preparing method |
JP2005295851A (en) * | 2004-04-08 | 2005-10-27 | Asahi Denka Kogyo Kk | Method for producing immobilized enzyme |
-
2006
- 2006-12-28 CN CNB2006101555239A patent/CN100455664C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104140961A (en) * | 2014-07-04 | 2014-11-12 | 浙江大学 | Immobilized lipase having Sn-1,3 specificity as well as preparation method and application of immobilized lipase |
CN109207466A (en) * | 2018-11-08 | 2019-01-15 | 山东鲁抗医药股份有限公司 | A kind of process for fixation and immobilised enzymes of PA ase |
CN109207466B (en) * | 2018-11-08 | 2021-01-08 | 山东鲁抗医药股份有限公司 | Immobilization method of penicillin acylase and immobilized enzyme |
CN110760496A (en) * | 2019-05-07 | 2020-02-07 | 宁波大学 | A kind of co-crosslinking immobilization method of penicillin G acylase |
CN110760496B (en) * | 2019-05-07 | 2023-03-21 | 宁波大学 | Co-crosslinking immobilization method of penicillin G acylase |
WO2021249433A1 (en) * | 2020-06-10 | 2021-12-16 | 华南理工大学 | Carrier for immobilizing protein and preparation method therefor |
Also Published As
Publication number | Publication date |
---|---|
CN100455664C (en) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Reis et al. | Design of immobilized enzyme biocatalysts: Drawbacks and opportunities | |
Datta et al. | Enzyme immobilization: an overview on techniques and support materials | |
Thangaraj et al. | Immobilization of lipases–a review. Part II: carrier materials | |
Wilson et al. | Encapsulation of crosslinked penicillin G acylase aggregates in lentikats: evaluation of a novel biocatalyst in organic media | |
US4141857A (en) | Support matrices for immobilized enzymes | |
CN102260662B (en) | Carrier for immobilized enzyme and application thereof and the carrier for being fixed with enzyme | |
CN101058824A (en) | Immobilized enzyme biological catalyst, preparation method and application | |
EP0104571B1 (en) | Immobilization of biocatalysts on granular carbon | |
CN100455664C (en) | Preparation and loading method of a carrier for immobilizing penicillin acylase | |
Li et al. | Recent progress in the development of immobilized penicillin G acylase for chemical and industrial applications: A mini‐review | |
CN1935994B (en) | Organic group functionized mesoporous molecular sieve enzyme immobilized carrier, and its preparing method | |
JPH0338B2 (en) | ||
CN102181422B (en) | Macropore carrier 'synchronization method' covalent crosslinking-immobilized papain polymer and method | |
KR940005581B1 (en) | Immobilization Method of Enzyme and Immobilized Enzyme | |
CN102703411B (en) | Paramagnetic epoxy-based mesoporous molecular sieve immobilized with biological enzyme and preparation method thereof | |
CN101508986B (en) | Immobilized penicillin acylated enzyme with silicon gel rubber as carrier and preparation method | |
CN103074322A (en) | Method for preparing immobilized lipase by utilizing amphipathy chitosan microsphere carrier | |
Wang et al. | Improving the stability and reusability of dextranase by immobilization on polyethylenimine modified magnetic particles | |
Bahulekar et al. | Immobilization of penicillin G acylase on functionalized macroporous polymer beads | |
CN113307359B (en) | A kind of composite carrier material for biological fluidized bed and preparation method thereof | |
Sun et al. | Preparation of 3D porous cellulose‐chitosan hybrid gel macrospheres by alkaline urea system for enzyme immobilization | |
CN1059759A (en) | The preparation method of complex solidifying enzyme | |
CN101851616B (en) | Aldehyde group mesoporous molecular sieve used for immobilization of biological enzyme and preparation method thereof | |
CN101864410A (en) | Epoxy-based mesoporous molecular sieve for biological enzyme immobilization and preparation method thereof | |
JPS596885A (en) | Production of insoluble living body catalyst |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hangzhou Huada Haitian Technology Co., Ltd. Assignor: Zhejiang University Contract fulfillment period: 2008.11.10 to 2018.11.9 contract change Contract record no.: 2009330001966 Denomination of invention: Penicillin acylation enzyme-fixing carrier preparation method and carrying method Granted publication date: 20090128 License type: Exclusive license Record date: 2009.8.14 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.11.10 TO 2018.11.9; CHANGE OF CONTRACT Name of requester: HANGZHOU HUADA HAITIAN TECHNOLOGY CO., LTD. Effective date: 20090814 |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090128 Termination date: 20131228 |